Sign in

CIK 0001469443

  • Non-accelerated filer
  • Smaller reporting company

Arcadia Biosciences, Inc.

Sign in to watch
Ticker
RKDA
Exchange
Nasdaq
Industry
Beverages
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
810571538
Phone
+1 214-974-8921
Business address
5956 SHERRY LANE, SUITE 2000, DALLAS, TX
  1. 4 Exercise or conversion VP Finance and Administration acquired 10,000 shares (option exercise)
  2. 4 Open-market sale President and CEO sold 21,636 shares at an average $3.07 ($66,417)
  3. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  4. 4 Open-market sale President and CEO sold 15,900 shares at an average $3.46 ($54,951)
  5. 4 Open-market sale President and CEO sold 21,089 shares at an average $4.27 ($90,131)
  6. 4 Open-market sale VP Regulatory and Compliance sold 3,521 shares at an average $4.95 ($17,433)
  7. 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 17,500 shares (option exercise)
  9. 4 Open-market sale VP Business Development sold 1,648 shares at $4.92 ($8,105)
  10. 4 Open-market sale VP Product Development sold 1,068 shares at $4.92 ($5,253)
  11. 4 Open-market sale VP Business Development sold 7,840 shares at an average $5.47 ($42,917)
  12. 4 Open-market sale VP Product Development sold 6,672 shares at an average $5.48 ($36,533)
  13. 4 Open-market sale Chief Scientific Officer sold 6,840 shares at an average $5.50 ($37,646)
  14. 4/A Open-market buy Director bought 375,000 shares at $8.00 ($3,000,000)
  15. 4/A Open-market buy 10% owner bought 375,000 shares at $8.00 ($3,000,000)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy 10% owner bought 375,000 shares at $8.00 ($3,000,000)
  18. 4 Open-market buy Director bought 375,000 shares at $8.00 ($3,000,000)
  19. 4 Open-market buy Director bought 1,000,000 shares at $8.00 ($8,000,000)
  20. 4 Derivatives Options or other derivatives

Page 9 of 11 · 203 filings